Citations

Showing 10 of 108162 citations.

A practical biomechanical model of the index finger simulating the kinematics of the muscle/tendon excursions
Wu, John Z. , An, Kai‐Nan , Cutlip, Robert G., Dong, Ren G.

Mayo Clinic

Bio-Medical Materials and Engineering | December 2, 2019 | Volume: 20 | Issue: 2 | Pages: 89-97

10.3233/bme-2010-0618 | PMID 20592446 Get It

Stereotactic radiosurgery for non-functioning pituitary adenomas: meta-analysis and International Stereotactic Radiosurgery Society practice opinion
Kotecha, Rupesh , Sahgal, Arjun , Rubens, Muni , Salles, Antônio De, Fariselli, Laura , Pollock, Bruce E. , Ma, Lijun , Paddick, Ian , Régis, Jean , Sheehan, Jason P. , Yomo, Shoji , Paddick, Ian , Levivier, Marc , Suh, John H.

Mayo Clinic

Neuro-Oncology | December 2, 2019 | Volume: 22 | Issue: 3 | Pages: 318-332

10.1093/neuonc/noz225 | PMID 31790121 Get It

Abstract Background This systematic review reports on outcomes and toxicities following stereotactic radiosurgery (SRS) for non-functioning pituitary adenomas (NFAs) and presents consensus opinions regarding appropriate patient management. Methods Using the guidelines of the Preferred Reporting Items for Systematic Reviews and Meta-Analyses, a systematic review was performed from articles of ≥10 patients with NFAs published prior to May 2018 from the Medline database using the key words “radiosurgery” and “pituitary” and/or “adenoma.” Weighted random effects models were used to calculate pooled outcome estimates. Results Of the 678 abstracts reviewed, 35 full-text articles were included describing the outcomes of 2671 patients treated between 1971 and 2017 with either single fraction SRS or hypofractionated stereotactic radiotherapy (HSRT). All studies were retrospective (level IV evidence). SRS was used in 27 studies (median dose: 15 Gy, range: 5–35 Gy) and HSRT in 8 studies (median total dose: 21 Gy, range: 12–25 Gy, delivered in 3–5 fractions). The 5-year random effects local control estimate after SRS was 94% (95% CI: 93.0–96.0%) and 97.0% (95% CI: 93.0–98.0%) after HSRT. The 10-year local control random effects estimate after SRS was 83.0% (95% CI: 77.0–88.0%). Post-SRS hypopituitarism was the most common treatment-related toxicity observed, with a random effects estimate of 21.0% (95% CI: 15.0–27.0%), whereas visual dysfunction or other cranial nerve injuries were uncommon (range: 0–7%). Conclusions SRS is an effective and safe treatment for patients with NFAs. Encouraging short-term data support HSRT for select patients, and mature outcomes are needed before definitive recommendations can be made. Clinical practice opinions were developed on behalf of the International Stereotactic Radiosurgery Society (ISRS).
Beyond involvement: multiple methods and purposes of shared decision making
Hargraves, Ian

Mayo Clinic

Journal of Comparative Effectiveness Research | December 2, 2019 | Volume: 8 | Issue: 16 | Pages: 1345-1347

10.2217/cer-2019-0149 | PMID 31789051 Get It

Obesity and metabolic health status are determinants for the clinical expression of hypertrophic cardiomyopathy
Park, Jun‐Bean , Lee, Heesun , Yoon, Yeonyee E. , Park, Hyo Eun , Choi, Su‐Yeon , Kim, Yong-Jin , Ommen, Steve R. , Kim, Hyung‐Kwan , Kim, Hyung-Kwan , Kim, Dahye , Hwang, In‐Chang , Yoon, Yeonyee Elizabeth , Cho, Goo‐Yeong , Han, Kyungdo

Mayo Clinic

European Journal of Preventive Cardiology | December 2, 2019 | Volume: 27 | Issue: 17 | Pages: 1849-1857

10.1177/2047487319889714 | PMID 31787021 Get It

Aims We sought to investigate the association of obesity and metabolic health status with the incidence of clinical hypertrophic cardiomyopathy (HCM) diagnosis in the general population. Our goal was to identify modifiable risk factors to attenuate clinical expression of HCM, enabling management evolution from a mostly passive strategy of risk stratification to a proactive strategy of modifying disease expression. Methods Using nationwide population-based data from the Korean National Health Insurance Service, 28,679,891 people who were free of prevalent HCM and who underwent health examinations between 2009 and 2015 were followed until 31 December 2016. The primary outcome was clinical HCM that was defined as incident diagnosis of HCM during the follow-up, after a blanking period of 12 months. Results Over a median follow-up of 5.2 years, 0.027% (n = 7851) of the study participants were diagnosed as incident HCM. The incidence rate per 1000 person-years was 0.059. A significant association was found between body mass index (BMI) and the incidence of clinical HCM after multivariate adjustment, with a hazard ratio per 1 kg/m2 increase in BMI of 1.063 (95% confidence interval 1.051–1.075). Metabolically unhealthy participants had a greater incidence of HCM than metabolically healthy participants, regardless of obesity status. The effect of BMI was more pronounced in several subgroups, including participants with no hypertension, those aged less than 65 years and men. Conclusion We found that individuals with obesity and/or metabolic abnormalities had a significantly higher incidence of clinical HCM diagnosis than their counterparts. Efforts to manage obesity and metabolic abnormalities may be important in modifying clinical expression of HCM.
Efficacy of Electrical Baroreflex Activation Is Independent of Peripheral Chemoreceptor Modulation
Heusser, Karsten , Thöne, Arvo, Lipp, Axel , Menne, Jan, Beige, Joachim , Reuter, Hannes , Hoffmann, Fabian , Halbach, Marcel , Eckert, Siegfried , Koziolek, Michael , Haarmann, Helge , Diedrich, André , Haller, Hermann , Tank, Jens , Wallbach, Manuel , Joyner, Michael J. , Paton, Julian F. R. , Jordan, Jens

Mayo Clinic

Hypertension | December 2, 2019 | Volume: 75 | Issue: 1 | Pages: 257-264

10.1161/hypertensionaha.119.13925 | PMID 31786986 Get It

Arterial baroreflex activation through electrical carotid sinus stimulation has been developed for the treatment of resistant hypertension. Previous studies suggested that the peripheral chemoreflex is tonically active in hypertensive patients and may inhibit baroreflex responses. We hypothesized that peripheral chemoreflex activation attenuates baroreflex efficacy evoked by electrical carotid sinus stimulation. We screened 35 patients with an implanted electrical carotid sinus stimulator. Of those, 11 patients with consistent acute depressor response were selected (7 men/4 women, age: 67±8 years, body mass index: 31.6±5.2 kg/m 2 , 6±2 antihypertensive drug classes). We assessed responses to electrical baroreflex stimulation during normoxia, isocapnic hypoxia (SpO 2 : 79.0±1.5%), and hyperoxia (40% end-tidal O 2 fraction) by measuring heart rate, blood pressure, ventilation, oxygen saturation, end-tidal CO 2 and O 2 fractions, and muscle sympathetic nerve activity. During normoxia, baroreflex activation reduced systolic blood pressure from 164±27 to 151±25 mm Hg (mean±SD, P <0.001), heart rate from 64±13 to 61±13 bpm ( P =0.002), and muscle sympathetic nerve activity from 42±12 to 36±12 bursts/min ( P =0.004). Hypoxia increased systolic blood pressure 8±12 mm Hg ( P =0.057), heart rate 10±6 bpm ( P <0.001), muscle sympathetic nerve activity 7±7 bursts/min ( P =0.031), and ventilation 10±7 L/min ( P =0.002). However, responses to electrical carotid sinus stimulation did not differ between hypoxic and hyperoxic conditions: systolic blood pressure: −15±7 versus −14±8 mm Hg ( P =0.938), heart rate: −2±3 versus −2±2 bpm ( P =0.701), and muscle sympathetic nerve activity: −6±4 versus −4±3 bursts/min ( P =0.531). We conclude that moderate peripheral chemoreflex activation does not attenuate acute responses to electrical baroreflex activation therapy in patients with resistant hypertension. These patients provided insight into human baroreflex-chemoreflex interactions that could not be gained otherwise.
Redesigning the Learning Environment to Promote Learner Well-Being and Professional Development
Lipscomb, Wanda, Thibault, George E., Dyrbye, Liselotte N.

Mayo Clinic

Academic Medicine | December 2, 2019 | Volume: 95 | Issue: 5 | Pages: 674-678

10.1097/acm.0000000000003094 | PMID 31789840 Get It

There is a high prevalence of burnout and depression among medical students and residents (or learners), which can negatively impact them personally, their professional development, and the patients to whom they provide care. Educators have a responsibility for the system-level factors that influence learners’ well-being. In this Invited Commentary, the authors outline strategies institutions and affiliated training sites responsible for educating learners can take to pursue the recommended goal related to learners, their well-being, and the learning environment in the National Academies of Sciences, Engineering, and Medicine consensus study report, Taking Action Against Clinician Burnout: A Systems Approach to Professional Well-Being .
Mesenchymal Stem Cell Therapy for Spinal Cord Contusion: A Comparative Study on Small and Large Animal Models
Mukhamedshina, Yana , Shulman, Iliya, Ogurcov, Sergei, Kostennikov, Alexander , Zakirova, Elena , Rogozhin, Alexander , Masgutova, Galina, James, Victoria , Masgutov, Ruslan , Lavrov, Igor , Rizvanov, Albert A. , Lavrov, Igor , Akhmetzyanova, Elvira Ruslanovna

Mayo Clinic

Biomolecules | December 2, 2019 | Volume: 9 | Issue: 12 | Pages: 811

10.3390/biom9120811 | PMID 31805639 Get It

Here, we provide a first comparative study of the therapeutic potential of allogeneic mesenchymal stem cells derived from bone marrow (BM-MSCs), adipose tissue (AD-MSCs), and dental pulp (DP-MSCs) embedded in fibrin matrix, in small (rat) and large (pig) spinal cord injury (SCI) models during subacute period of spinal contusion. Results of behavioral, electrophysiological, and histological assessment as well as immunohistochemistry and real-time polymerase chain reaction analysis suggest that application of AD-MSCs combined with a fibrin matrix within the subacute period in rats (2 weeks after injury), provides significantly higher post-traumatic regeneration compared to a similar application of BM-MSCs or DP-MSCs. Within the rat model, use of AD-MSCs resulted in a marked change in: (1) restoration of locomotor activity and conduction along spinal axons; (2) reduction of post-traumatic cavitation and enhancing tissue retention; and (3) modulation of microglial and astroglial activation. The effect of an autologous application of AD-MSCs during the subacute period after spinal contusion was also confirmed in pigs (6 weeks after injury). Effects included: (1) partial restoration of the somatosensory spinal pathways; (2) reduction of post-traumatic cavitation and enhancing tissue retention; and (3) modulation of astroglial activation in dorsal root entry zone. However, pigs only partially replicated the findings observed in rats. Together, these results indicate application of AD-MSCs embedded in fibrin matrix at the site of SCI during the subacute period can facilitate regeneration of nervous tissue in rats and pigs. These results, for the first time, provide robust support for the use of AD-MSC to treat subacute SCI.
Primary reverse shoulder arthroplasty in patients older than 80 years of age
Samuelsen, Brian T. , Assenmacher, Andrew T. , Cofield, Robert H. , Sperling, John W. , Clark, Nicholas J. , Alentorn-Geli, Eduard, Sanchez-Sotelo, Joaquin, Clark, Nicholas , Alentorn‐Geli, Eduard , Sánchez‐Sotelo, Joaquín

Mayo Clinic

The Bone & Joint Journal | December 2, 2019 | Volume: 101-B | Issue: 12 | Pages: 1520-1525

10.1302/0301-620x.101b12.bjj-2018-1571.r2 | PMID 31787000 Get It

Aims Reverse shoulder arthroplasty (RSA) reliably improves shoulder pain and function for a variety of indications. However, the safety and efficacy of RSA in elderly patients is largely unknown. The purpose of this study was to report the mortality, morbidity, complications, reoperations, and outcomes of primary RSA in patients aged > 80 years. Patients and Methods Between 2004 and 2013, 242 consecutive primary RSAs were performed in patients aged > 80 years (mean 83.3 years (sd 3.1)). Of these, 53 were lost to follow-up before two years and ten had died within two years of surgery, leaving 179 for analysis of survivorship, pain, motion, and strength at a minimum of two years or until revision surgery. All 242 patients were considered for the analysis of 90-day, one-year, and overall mortality, medical complications (90-day and overall), surgical complications, and reoperations. The indications for surgery included rotator cuff arthropathy, osteoarthritis, fracture, the sequela of trauma, avascular necrosis, and rheumatoid arthritis. A retrospective review of the medical records was performed to collect all variables. Survivorship free of revision surgery was calculated at two and five years. Results One patient (0.4%) died within the first 90 days. A total of 45 patients (19%) were known to have died at the time of the final follow-up, with a median time to death of 67.7 months (interquartile range 40.4 to 94.7) postoperatively. Medical complications occurred in six patients (3%) and surgical complications occurred in 21/179 patients (12%). Survivorship free from revision was 98.9% at two years and 98.3% at five years; survivorship free from loosening was 99.5% at final follow-up. The presence of peripheral vascular disease correlated with a higher complication rate. Conclusion Primary RSA was safe and effective in patients aged > 80 years, with a relatively low rate of medical and surgical complications. Thus, age alone should not be a contraindication to primary RSA in patients aged > 80 years. However, a careful evaluation of comorbidities is required in this age group when considering primary RSA. Cite this article: Bone Joint J 2019;101-B:1520–1525
Physician-Modified Endograft With Double Inner Branches for Urgent Repair of Supraceliac Para-Anastomotic Pseudoaneurysm
D’Oria, Mario , Mirza, Aleem K. , Tenorio, Emanuel R. , Oderich, Gustavo S. , Kärkkäinen, Jussi M, DeMartino, Randall R. , Tenorio, Emanuel R , D'Oria, Mario , Kärkkäinen, Jussi M. , Oderich, Gustavo S.

Mayo Clinic

Journal of Endovascular Therapy | December 2, 2019 | Volume: 27 | Issue: 1 | Pages: 124-129

10.1177/1526602819890108 | PMID 31789079 Get It

Purpose: To demonstrate the feasibility of a physician-modified endograft (PMEG) with inner branches for 2 mesenteric arteries as an alternative to fenestrations or directional branches. Technique: A symptomatic 60-year-old man presented with supraceliac para-anastomotic pseudoaneurysm involving an antegrade aorta to celiac artery and superior mesenteric artery bypass. Since an off-the-shelf multibranched endograft was inappropriate, a Zenith Alpha thoracic stent-graft was modified with 2 inner branches fashioned of 8-mm Viabahn endoprostheses with preloaded guidewires. The procedure was technically successful, and the patient had no postoperative complications. Conclusion: Inner branches might offer an alternative to fenestrations or directional branches in patients with narrow aortas.